Article Details
Retrieved on: 2021-05-03 17:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Anodyne Nanotech's primary focus is now on biologics, and we have shown delivery of monoclonal antibodies and peptides in vivo. I believe our ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here